Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

JOURDE

Showing results (191-200 of 230) with videos related to

Pageof 23
Sort By:
American Journal of Human Genetics|July 27, 2022
Monoallelic pathogenic ALG5 variants cause atypical polycystic kidney disease and interstitial fibrosisHugo Lemoine, Loann Raud, François Foulquier, et al.
RMD Open|March 17, 2022
Comparative study of granulomatosis with polyangiitis subsets according to ANCA status: data from the French Vasculitis Study Group RegistryXavier Puéchal, Michele Iudici, Christian Pagnoux, et al.
Clinical Kidney Journal|August 5, 2024
Kidney involvement in myelodysplastic syndromesMarie-Camille Lafargue, Jean-Paul Duong Van Huyen, Helmut G Rennke, et al.
Clinical Kidney Journal|December 23, 2020
Risk factors for severity of COVID-19 in chronic dialysis patients from a multicentre French cohortGuillaume Lano, Antoine Braconnier, Stanislas Bataille, et al.
Rheumatology (Oxford, England)|March 10, 2020
Reducing the initial number of rituximab maintenance-therapy infusions for ANCA-associated vasculitides: randomized-trial post-hoc analysisPierre Charles, Agnès Dechartres, Benjamin Terrier, et al.
Annals of the Rheumatic Diseases|April 27, 2018
Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)Pierre Charles, Benjamin Terrier, Élodie Perrodeau, et al.
Rheumatology (Oxford, England)|September 20, 2021
Localized versus systemic granulomatosis with polyangiitis: data from the French Vasculitis Study Group RegistryMichele Iudici, Christian Pagnoux, Delphine S Courvoisier, et al.
British Journal of Clinical Pharmacology|May 24, 2025
Population pharmacokinetic modelling of prednisolone in systemic lupus erythematosus patients: Analysis of exposure and disease activityNaïm Bouazza, Michaela Semeraro, Gabrielle Lui, et al.
Nature Communications|January 22, 2016
D25V apolipoprotein C-III variant causes dominant hereditary systemic amyloidosis and confers cardiovascular protective lipoprotein profileSophie Valleix, Guglielmo Verona, Noémie Jourde-Chiche, et al.
Seminars in Arthritis and Rheumatism|February 18, 2021
Granulomatosis with polyangiitis: Study of 795 patients from the French Vasculitis Study Group registryMichele Iudici, Christian Pagnoux, Delphine S Courvoisier, et al.
Pageof 23

Showing results (191-200 of 230) with videos related to

Sort By:
Pageof 23
American Journal of Human Genetics|July 27, 2022
Monoallelic pathogenic ALG5 variants cause atypical polycystic kidney disease and interstitial fibrosisHugo Lemoine, Loann Raud, François Foulquier, et al.
RMD Open|March 17, 2022
Comparative study of granulomatosis with polyangiitis subsets according to ANCA status: data from the French Vasculitis Study Group RegistryXavier Puéchal, Michele Iudici, Christian Pagnoux, et al.
Clinical Kidney Journal|August 5, 2024
Kidney involvement in myelodysplastic syndromesMarie-Camille Lafargue, Jean-Paul Duong Van Huyen, Helmut G Rennke, et al.
Clinical Kidney Journal|December 23, 2020
Risk factors for severity of COVID-19 in chronic dialysis patients from a multicentre French cohortGuillaume Lano, Antoine Braconnier, Stanislas Bataille, et al.
Rheumatology (Oxford, England)|March 10, 2020
Reducing the initial number of rituximab maintenance-therapy infusions for ANCA-associated vasculitides: randomized-trial post-hoc analysisPierre Charles, Agnès Dechartres, Benjamin Terrier, et al.
Annals of the Rheumatic Diseases|April 27, 2018
Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)Pierre Charles, Benjamin Terrier, Élodie Perrodeau, et al.
Rheumatology (Oxford, England)|September 20, 2021
Localized versus systemic granulomatosis with polyangiitis: data from the French Vasculitis Study Group RegistryMichele Iudici, Christian Pagnoux, Delphine S Courvoisier, et al.
British Journal of Clinical Pharmacology|May 24, 2025
Population pharmacokinetic modelling of prednisolone in systemic lupus erythematosus patients: Analysis of exposure and disease activityNaïm Bouazza, Michaela Semeraro, Gabrielle Lui, et al.
Nature Communications|January 22, 2016
D25V apolipoprotein C-III variant causes dominant hereditary systemic amyloidosis and confers cardiovascular protective lipoprotein profileSophie Valleix, Guglielmo Verona, Noémie Jourde-Chiche, et al.
Seminars in Arthritis and Rheumatism|February 18, 2021
Granulomatosis with polyangiitis: Study of 795 patients from the French Vasculitis Study Group registryMichele Iudici, Christian Pagnoux, Delphine S Courvoisier, et al.
Pageof 23